April 10 (Reuters) - Pfizer (PFE.N), opens new tab subsidiary Wyeth has agreed to pay $39 million to resolve claims from drug purchasers that it conspired with rival Teva to delay launching a less-expensive version of the antidepressant drug Effexor XR.
Venlafaxine 37.5mg/5ml and 75mg/5ml oral solution sugar free are to be removed from Part VIIIB of the November 2021 Drug Tariff. This is because licenced alternatives, Venlafaxine 37.5mg/5ml oral solution sugar free 150 ml and Venlafaxine 75mg/5ml oral solution sugar free 150 ml (Rosemont Pharmaceuticals Ltd) are now available and will be added to Part VIIIA (category C) of the November 2021 Drug Tariff.
Enforcement Report - Week of August 18, 2021
Health Canada Issues Recall of Venlafaxine XR Product
Philadelphia crack down on pharma reps with registration, gift banning
Philadelphia crack down on pharma reps with registration, gift banning
The Madras High Court has issued an order in favour of Sun Pharmaceuticals in a trademark dispute it has raised against Cadila Healthcare for the trademark of its depressive disorder drug VENIZ. The Court issued a permanent injunction against the latter using marks similar to Sun Pharma's particular trademark.
US FDA Enforcement Report- 11/May/2016
A team of researchers has come up with a two-drug combo that can help older adults with hard-to-treat depression.nMore than half of older adults with clinical depression don’t get better when treated with an antidepressant, but results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug, an antipsychotic medication, to the treatment regimen helps many of those patients.
Recalled ProductsnnAPO-Venlafaxine XRnnReasonnOut of specification result for potency during shelf life testing.nnDepth of distributionnWholesalers and DistributorsnnAffected productsnAPO-Venlafaxine XRnDIN, NPN, DIN-HIMnnDIN 02331691nDosage formnnCapsule (Extended Release)nnStrengthnnVenlafaxine 75 mg